Cliff Asness's AMGN Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 205.8K shares of Amgen Inc. (AMGN) worth $57.24 M, representing 0.04% of the portfolio. First purchased in 2012-Q4, this long-term strategic position has been held for 52 quarters.
Based on 13F filings since 2013, Cliff Asness has maintained a long-term strategic position in AMGN, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2017, adding 1.4M shares. Largest reduction occurred in Q2 2019, reducing 1.1M shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Amgen (AMGN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Amgen (AMGN) Trades by Cliff Asness
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2012 | +1.72 M | Add 0.00% | 1.72 M | $86.32 |
| Q2 2013 | +2.02 M | Add 0.00% | 2.02 M | $98.66 |
| Q3 2013 | -398,185 | Reduce 19.69% | 1.62 M | $111.94 |
| Q4 2013 | -144,473 | Reduce 8.89% | 1.48 M | $114.16 |
| Q1 2014 | -561,856 | Reduce 37.97% | 918,016 | $123.34 |
| Q2 2014 | -260,220 | Reduce 28.35% | 657,796 | $118.37 |
| Q3 2014 | -219,816 | Reduce 33.42% | 437,980 | $140.46 |
| Q4 2014 | +489,761 | Add 111.82% | 927,741 | $159.29 |
| Q1 2015 | +884,162 | Add 95.30% | 1.81 M | $159.85 |
| Q2 2015 | +751,701 | Add 41.49% | 2.56 M | $153.52 |
| Q3 2015 | +170,823 | Add 6.66% | 2.73 M | $138.32 |
| Q4 2015 | -692,683 | Reduce 25.33% | 2.04 M | $162.33 |
| Q1 2016 | -769,121 | Reduce 37.67% | 1.27 M | $149.93 |
| Q2 2016 | -319,484 | Reduce 25.10% | 953,139 | $152.15 |
| Q3 2016 | +28,188 | Add 2.96% | 981,327 | $166.81 |
| Q4 2016 | +69,264 | Add 7.06% | 1.05 M | $146.21 |
| Q1 2017 | +392,538 | Add 37.36% | 1.44 M | $164.07 |
| Q2 2017 | +94,867 | Add 6.57% | 1.54 M | $172.23 |
| Q3 2017 | +1.39 M | Add 90.31% | 2.93 M | $186.45 |
| Q4 2017 | +714,906 | Add 24.42% | 3.64 M | $173.90 |
| Q1 2018 | -743,483 | Reduce 20.41% | 2.9 M | $170.48 |
| Q2 2018 | -764,378 | Reduce 26.37% | 2.13 M | $184.59 |
| Q3 2018 | +773,506 | Add 36.25% | 2.91 M | $207.29 |
| Q4 2018 | +177,493 | Add 6.10% | 3.09 M | $194.67 |
| Q1 2019 | -322,075 | Reduce 10.44% | 2.76 M | $189.98 |
| Q2 2019 | -1.07 M | Reduce 38.68% | 1.69 M | $184.28 |
| Q3 2019 | -496,897 | Reduce 29.33% | 1.2 M | $193.51 |
| Q4 2019 | +182,509 | Add 15.24% | 1.38 M | $240.03 |
| Q1 2020 | +368,603 | Add 26.71% | 1.75 M | $200.92 |
| Q2 2020 | -367,555 | Reduce 21.02% | 1.38 M | $232.29 |
| Q3 2020 | -182,304 | Reduce 13.20% | 1.2 M | $250.38 |
| Q4 2020 | -139,105 | Reduce 11.60% | 1.06 M | $226.03 |
| Q1 2021 | +70,114 | Add 6.62% | 1.13 M | $248.44 |
| Q2 2021 | +72,616 | Add 6.43% | 1.2 M | $242.38 |
| Q3 2021 | -18,128 | Reduce 1.51% | 1.18 M | $212.65 |
| Q4 2021 | -297,260 | Reduce 25.10% | 886,995 | $224.97 |
| Q1 2022 | -154,224 | Reduce 17.39% | 732,771 | $241.82 |
| Q2 2022 | -165,312 | Reduce 22.56% | 567,459 | $241.89 |
| Q3 2022 | +58,049 | Add 10.23% | 625,508 | $225.40 |
| Q4 2022 | -18,991 | Reduce 3.04% | 606,517 | $261.70 |
| Q1 2023 | +39,731 | Add 6.55% | 646,248 | $241.26 |
| Q2 2023 | +63,736 | Add 9.86% | 709,984 | $221.94 |
| Q3 2023 | +87,760 | Add 12.36% | 797,744 | $268.76 |
| Q4 2023 | +144,153 | Add 18.07% | 941,897 | $287.20 |
| Q1 2024 | -684,325 | Reduce 72.65% | 257,572 | $284.32 |
| Q2 2024 | -184,448 | Reduce 71.61% | 73,124 | $312.45 |
| Q3 2024 | +47,619 | Add 65.12% | 120,743 | $320.94 |
| Q4 2024 | -75,667 | Reduce 62.67% | 45,076 | $260.63 |
| Q1 2025 | +46,417 | Add 102.97% | 91,493 | $309.54 |
| Q2 2025 | +177,767 | Add 194.30% | 269,260 | $278.47 |
| Q3 2025 | -63,476 | Reduce 23.57% | 205,784 | $278.16 |
Cliff Asness's Amgen Investment FAQs
Cliff Asness first purchased Amgen Inc. (AMGN) in Q4 2012, acquiring 1,716,497 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Amgen Inc. (AMGN) for 52 quarters since Q4 2012. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness's largest addition to Amgen Inc. (AMGN) was in Q2 2013, adding 2,022,530 shares worth $199.54 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 205,784 shares of Amgen Inc. (AMGN), valued at approximately $57.24 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Amgen Inc. (AMGN) represents approximately 0.04% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness's peak holding in Amgen Inc. (AMGN) was 3,641,930 shares, as reported at the end of Q4 2017. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.